Compound Electrolyte Glucose Injection-M3A
Function and Efficacy
In rabbits within 4 days of surgical invasion, the electrolytes (Na, K, C1) were maintained in a good balance from the first to the fourth day after surgery by intravenous drip of 50ml/kg/d. In addition, blood pH, PC02, and H2CO3 also returned to preoperative values on the fifth day after surgery, and plasma non-protein nitrogen (NPN) concentration also dropped to preoperative values on the third day after surgery, so it is an effective postoperative maintenance fluid.
Ingredients
This product is a compound preparation, and its main components per 1000ml are: 2.34g sodium chloride, 0.75g potassium chloride, 2.24g sodium lactate, and 27.00g glucose.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Sodium chlorideIngredients |
Maintain electrolyte balance, stabilize blood pH and recover after surgery More |
7647-14-5 | 43 | |
| Potassium chlorideIngredients |
Maintain electrolyte balance, stabilize blood pH and recover after surgery More |
7447-40-7 | 39 | |
| Sodium lactateIngredients |
Maintain electrolyte balance, stabilize blood pH and recover after surgery More |
312-85-6 | 0 | |
| GLUCOSEIngredients |
Maintain electrolyte balance, stabilize blood pH and recover after surgery More |
58367-01-4 | 15 |
Appearance
This product is a colorless or almost colorless clear liquid.
Indication
Fluid and electrolyte replenisher. Replenishes and maintains fluids and electrolytes when oral intake is impossible or insufficient.
Usage and Dosage
For adults, 500-1000 ml of intravenous drip at a time. The administration rate is 300-500 ml per hour (about 80-130 drops per minute); for children, 50-100 ml per hour, and the dosage can be increased or decreased appropriately according to age, weight, and symptoms.
Adverse Reactions
When large amounts of the drug are administered rapidly, pulmonary edema, cerebral edema, peripheral edema, water intoxication, and hyperkalemia may occur.
Precautions
1. Hyperlactatemia; 2. Patients with hyperkalemia, oliguria, Addison's disease, severe burns, and hyperazotemia; 3. Patients with renal insufficiency without hyperkalemia; 4. Patients with heart failure; 5. Patients with severe liver failure; 6. Patients with decreased urine volume due to obstructive urinary tract disease; 7. Patients with diabetes.
Drug Interactions
Not yet clear.
Storage
Keep tightly closed.
Packaging Specification
500ml
Manufacturer
Guangdong Otsuka Pharmaceutical Co., Ltd.
-
Founded in:
1993-06-01 -
Address:
Foshan Shunde District Ronggui Street High-tech Industrial Development Park -
Tax NO.:
91440606617475057M -
Registered Funds:
$28.4 million -
Website:
-
Email: